{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:15:04Z","timestamp":1789596904402,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To assess whether coronavirus disease 2019 (COVID-19) mRNA vaccination is associated with controlled ovarian hyperstimulation or early pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This retrospective cohort study included patients who underwent controlled ovarian hyperstimulation or single euploid frozen-thawed embryo transfer at a single academic center. Patients fully vaccinated with a COVID-19 mRNA vaccine were compared with unvaccinated patients who cycled during the same time period. The primary outcome was the fertilization rate for controlled ovarian hyperstimulation and the clinical pregnancy rate for frozen-thawed embryo transfer. Secondary outcomes for controlled ovarian hyperstimulation included eggs retrieved, mature oocytes retrieved, mature oocytes ratio, blastulation rate, and euploid rate. Secondary outcomes for frozen-thawed embryo transfer included pregnancy rate, ongoing pregnancy rate, biochemical pregnancy loss rate, and clinical pregnancy loss rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Among 222 vaccinated patients and 983 unvaccinated patients who underwent controlled ovarian hyperstimulation cycles between February and September 2021, there was no association on adjusted analysis between COVID-19 vaccination and fertilization rate (\u03b2=0.02\u00b10.02,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.20) or any of the secondary outcomes assessed: eggs retrieved (\u03b2=0.01\u00b10.57,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.99), mature oocytes retrieved (\u03b2=0.26\u00b10.47,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.58), mature oocytes ratio (\u03b2=0.02\u00b10.01,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.12), blastulation rate (\u03b2=0.02\u00b10.02,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.27), or euploid rate (\u03b2=0.05\u00b10.03,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.08). Among 214 vaccinated patients and 733 unvaccinated patients undergoing single euploid frozen-thawed embryo transfer, adjusted analysis demonstrated no significant association between vaccination and clinical pregnancy (adjusted odds ratio [aOR] 0.79, 95% CI 0.54\u20131.16) or any of the secondary outcomes: pregnancy (aOR 0.88, 95% CI 0.58\u20131.33), ongoing pregnancy (aOR 0.90, 95% CI 0.61\u20131.31), biochemical pregnancy loss (aOR 1.21, 95% CI 0.69\u20132.14), or clinical pregnancy loss (aOR 1.02, 95% CI 0.51\u20132.06).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Administration of COVID-19 mRNA vaccines was not associated with an adverse effect on stimulation or early pregnancy outcomes after IVF. Our findings contribute to the growing body of evidence regarding the safety of COVID-19 vaccination in women who are trying to conceive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004713","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T08:00:25Z","timestamp":1643184025000},"page":"490-497","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":74,"title":["In Vitro Fertilization and Early Pregnancy Outcomes After Coronavirus Disease 2019 (COVID-19) Vaccination"],"prefix":"10.1097","volume":"139","author":[{"given":"Devora","family":"Aharon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atoosa","family":"Ghofranian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Hernandez-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Canon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Gounko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Buyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Copperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/humrep\/deab238","article-title":"Effects of COVID-19 and mRNA vaccines on human fertility","volume":"37","author":"Chen","year":"2021","journal-title":"Hum Reprod"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajog.2020.07.045","article-title":"Are clinical outcomes worse for pregnant women at \u226520 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching","volume":"223","author":"Badr","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"E540","DOI":"10.1503\/cmaj.202604","article-title":"The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis","volume":"193","author":"Wei","year":"2021","journal-title":"CMAJ"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat Med"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/AOG.0000000000004290","article-title":"Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know","volume":"137","author":"Rasmussen","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2113891","article-title":"Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion","volume":"385","author":"Zauche","year":"2021","journal-title":"N Engl J Med"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.vaccine.2021.09.012","article-title":"Prenatal maternal COVID-19 vaccination and pregnancy outcomes","volume":"39","author":"Wainstock","year":"2021","journal-title":"Vaccine"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/uog.23729","article-title":"Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine","volume":"58","author":"Bookstein Peretz","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41577-021-00525-y","article-title":"Are COVID-19 vaccines safe in pregnancy?","volume":"21","author":"Male","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R16-20260916","first-page":"238","article-title":"Exaptation of retroviral syncytin for development of syncytialized placenta, its limited homology to the SARS-CoV-2 spike protein and arguments against disturbing narrative in the context of COVID-19 vaccination","volume":"10","author":"Kloc","year":"2021","journal-title":"Biology (Basel)"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12958-021-00757-6","article-title":"Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?","volume":"19","author":"Orvieto","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/deab182","article-title":"Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination","volume":"36","author":"Bentov","year":"2021","journal-title":"Hum Reprod"},{"key":"R19-20260916","first-page":"253","article-title":"SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility","volume":"2","author":"Morris","year":"2021","journal-title":"F S Rep"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous abortion following COVID-19 vaccination during pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMc2114466","article-title":"Covid-19 vaccination during pregnancy and first-trimester miscarriage","volume":"385","author":"Magnus","year":"2021","journal-title":"N Engl J Med"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10815-016-0647-y","article-title":"Reproductive outcome is optimized by genomic embryo screening, vitrification, and subsequent transfer into a prepared synchronous endometrium","volume":"33","author":"Rodriguez-Purata","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rbmo.2018.03.023","article-title":"Blastocyst vitrification, cryostorage and warming does not affect live birth rate, infant birth weight or timing of delivery","volume":"37","author":"Sekhon","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/humrep\/dez129","article-title":"What is the reproductive potential of day 7 euploid embryos?","volume":"34","author":"Hernandez-Nieto","year":"2019","journal-title":"Hum Reprod"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:44Z","timestamp":1789556564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004713","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"2021-12-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}